Clinical and Translational Science Workforce Development through a Statewide Community College Partnership

通过全州社区学院合作伙伴关系进行临床和转化科学劳动力发展

基本信息

项目摘要

Summary This R25 Research Education Module, leveraging the infrastructure of the Indiana Clinical and Translational Sciences Institute (I-CTSI), will foster development of a diverse clinical and translational workforce within Indiana through education and immersive experiences of learners from historically marginalized backgrounds enrolled in Ivy Tech, our statewide community college system. The clinical and translational science workforce is lacking diversity. This has profound negative consequences across the translational spectrum. There is strong evidence that career exposure and experiences have a positive impact on career choices. Ivy Tech is the largest singly accredited statewide community college system in the country, with campuses across Indiana and an undergraduate enrollment of ~120,000. Over half of all the Black/African American or Hispanic/Latinx undergraduate learners in the Indiana public education undergraduate system attend Ivy Tech. The numerous majors at Ivy Tech that have connections to clinical and translational research make this an ideal platform to engage learners into these careers. Herein, we propose to combine career exploration with an immersion research experience to help learners develop a pathway toward the clinical and translational science workforce. Our program has three components. The first (AIM 1), focused on broad exposure to learners about careers in clinical and translational science, will be achieved through synchronous virtual programming across the statewide Ivy Tech system. The second (AIM 2a), focused on immersion research experiences, will connect learners, termed CTSI-Scholars from Ivy Tech campuses near one of the four University campuses of our I-CTSI (Notre Dame, Purdue, Indiana-Bloomington, and Indiana-Indianapolis) into a 10-week summer experience. These Universities each have thematic foci of clinical and translational research/science that will serve as primary research experiences. The program will prioritize learners from historically marginalized populations as CTSI/Ivy Tech Scholars. The third program component (AIM 2b), will provide support through a cohort-based longitudinal mentoring/professional development, focused on career-pathway attainment over the subsequent year. The program's efficacy will be determined (AIM 3) through evaluation of learner progression into educational tracks/careers connected to clinical and translational science. The Overall proposal is led by a Multi- PI team, who serve as co-Directors of Workforce Development program in the I-CTSI. They bring complementary expertise to the leadership and are supported by an Advisory Committee of leaders at Ivy Tech and the I-CTSI as well as numerous program staff from both entities.
摘要 此R25研究教育模块,利用印第安纳州临床和翻译学院的基础设施 科学研究所(i-CTSI),将促进印第安纳州多样化的临床和翻译劳动力的发展 通过教育和来自历史边缘化背景的学习者的身临其境的体验 在常春藤理工大学,我们的全州社区学院系统。临床和转化科学人才队伍缺乏 多样性。这对整个翻译领域都产生了深远的负面影响。有强有力的证据表明 职业接触和经历对职业选择有积极的影响。常春藤科技是世界上最大的单打 全国认可的全州社区学院系统,在印第安纳州和 本科生招生人数为12万人。超过一半的黑人/非裔美国人或西班牙裔/拉丁裔 印第安纳州公共教育本科系统的本科生就读于常春藤理工大学。众多的 常春藤理工大学与临床和转化研究有关的专业使这一平台成为理想的平台 让学习者参与到这些职业中来。在此,我们建议将职业探索与沉浸相结合 研究经验,帮助学习者开发一条通往临床和转化科学劳动力的途径。 我们的计划有三个组成部分。第一个(目标1),重点是让学习者广泛接触到 临床和转化科学,将通过同步虚拟编程实现 全州常春藤科技系统。第二个(AIM 2a),专注于沉浸研究体验,将与 学员,被称为CTSI-学者,来自我们I-CTSI的四个大学校区之一的常春藤理工校区 (巴黎圣母院、普渡、印第安纳-布鲁明顿和印第安纳-印第安纳波利斯)进入为期10周的夏季体验。 每所大学都有临床和转化性研究/科学的主题重点,将作为 初步研究经验。该计划将优先考虑来自历史边缘人群的学习者 CTSI/常春藤科技学者。第三个方案构成部分(目标2b)将通过以队列为基础的 纵向指导/职业发展,重点是在随后的职业生涯中实现职业道路 年。该计划的有效性将通过评估学习者的进步来确定(AIM 3) 与临床和转化科学相关的教育跟踪/职业。整个提案是由多个- PI团队,他们担任I-CTSI劳动力发展项目的联席主任。它们带来了互补性 向领导层提供专业知识,并得到常春藤科技和i-CTSI领导人咨询委员会的支持 以及来自这两个实体的众多项目工作人员。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthew R Allen其他文献

Matthew R Allen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthew R Allen', 18)}}的其他基金

Precision medicine approaches to renal osteodystrophy
肾性骨营养不良症的精准医学方法
  • 批准号:
    10685341
  • 财政年份:
    2022
  • 资助金额:
    $ 10.8万
  • 项目类别:
Precision medicine approaches to renal osteodystrophy
肾性骨营养不良症的精准医学方法
  • 批准号:
    10539650
  • 财政年份:
    2022
  • 资助金额:
    $ 10.8万
  • 项目类别:
Treating bone deterioration associated with chronic kidney disease
治疗与慢性肾病相关的骨质恶化
  • 批准号:
    10343760
  • 财政年份:
    2016
  • 资助金额:
    $ 10.8万
  • 项目类别:
Pathogenesis of compromised bone quality and mechanics in chronic kidney disease.
慢性肾脏病中骨质量和力学受损的发病机制。
  • 批准号:
    9751842
  • 财政年份:
    2016
  • 资助金额:
    $ 10.8万
  • 项目类别:
Treating bone deterioration associated with chronic kidney disease
治疗与慢性肾病相关的骨质恶化
  • 批准号:
    9142786
  • 财政年份:
    2016
  • 资助金额:
    $ 10.8万
  • 项目类别:
Treating bone deterioration associated with chronic kidney disease
治疗与慢性肾病相关的骨质恶化
  • 批准号:
    10554260
  • 财政年份:
    2016
  • 资助金额:
    $ 10.8万
  • 项目类别:
Enhancing bone strength using combination drug therapy
使用联合药物疗法增强骨强度
  • 批准号:
    8303617
  • 财政年份:
    2012
  • 资助金额:
    $ 10.8万
  • 项目类别:
Enhancing bone strength using combination drug therapy
使用联合药物疗法增强骨强度
  • 批准号:
    8581777
  • 财政年份:
    2012
  • 资助金额:
    $ 10.8万
  • 项目类别:
Enhancing bone strength using combination drug therapy
使用联合药物疗法增强骨强度
  • 批准号:
    8825726
  • 财政年份:
    2012
  • 资助金额:
    $ 10.8万
  • 项目类别:
Enhancing bone strength using combination drug therapy
使用联合药物疗法增强骨强度
  • 批准号:
    9012010
  • 财政年份:
    2012
  • 资助金额:
    $ 10.8万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 10.8万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 10.8万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 10.8万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 10.8万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 10.8万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 10.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了